
Sign up to save your podcasts
Or


Mark McKenna from Prometheus Biosciences and Josh Kennedy-Smith from RTW Investments tell us about the white-knuckle ride that is building a pharmaceutical start-up, their passion for providing better care solutions for patients, the recent deal with Merck and the power of a strong partnership with your investor.
Host: Josh Baldwin, RTW Investments
Featuring: Mark McKenna, CEO of Prometheus Biosciences and Josh Kennedy-Smith, Managing Director; Research Analyst of RTW Investments.
FOLLOW US
Love our podcast? Follow us on LinkedIn at RTW Investments, LP and check out our website for the latest updates and insights.
To make sure you never miss an episode, you can subscribe to the RTW podcast on Spotify, Apple Podcasts, Amazon Music, and most other podcast platforms.
DISCLAIMER
Statements reflect RTW’s views and opinions as of the date hereof and not as of any future date. All expressions of opinion are subject to change without notice and are not intended to be a forecast of future events or results.
From the publisher's feed
We’re witnessing a healthcare revolution, as medical and science innovations transform the lives of millions. Join as we speak to bright scientific minds, inspiring company founders and healthcare…
Subscribe to catch each episode as it goes live.
The content of this podcast does not constitute investment advice, an offer to provide investment advisory services, or an offer to sell or solicitation of an offer to buy an interest in any investment fund.